The endothelin-1 G5665T polymorphism impacts transplant-free survival for single ventricle patients

Journal of Thoracic and Cardiovascular Surgery

Volumn 136, Issue 1, 2008, Pages 117-122

  Kirshbom, Paul M ^a   Mahle, William T ^a   Joyner, Ronald W ^a   Leong, Traci ^a   Wilson, Malania ^a   Kogon, Brian E ^a   Kanter, Kirk R ^a   Bouzyk, Mark M ^a  

^a CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1;

ARTICLE; DNA ISOLATION; FEMALE; GENETIC VARIABILITY; GENOTYPE; HEART SINGLE VENTRICLE; HUMAN; HUMAN TISSUE; HYPOPLASTIC LEFT HEART SYNDROME; MAJOR CLINICAL STUDY; MALE; PREMATURITY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL; SURVIVAL RATE;

DISEASE-FREE SURVIVAL; DNA; ENDOTHELIN-1; FEMALE; FONTAN PROCEDURE; GENOTYPE; HEART VENTRICLES; HUMANS; HYPOPLASTIC LEFT HEART SYNDROME; INFANT, NEWBORN; MALE; PALLIATIVE CARE; POLYMORPHISM, SINGLE NUCLEOTIDE; TREATMENT OUTCOME;

EID: 46049120428     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2008.02.040     Document Type: Article

References (11)

1. Gentles T., Mayer J.J., Gauvreau K., et al. Fontan operation in five hundred consecutive patients: factors influencing early and late outcome. J Thorac Cardiovasc Surg 114 (1997) 376-391
2. Mitchell M., Ittenbach R., Gaynor J., et al. Intermediate outcomes after the Fontan procedure in the current era. J Thorac Cardiovasc Surg 131 (2006) 172-180
3. Abraham M., Olson L., Joyner M., et al. Angiotensin-converting enzyme genotype modulates pulmonary function and exercise capacity in treated patients with congestive stable heart failure. Circulation 106 (2002) 1794-1799
4. Andersson B., and Sylven C. The DD genotype of the angiotensin-converting enzyme gene is associated with increased mortality in idiopathic heart failure. J Am Coll Cardiol 28 (1996) 162-167
5. Perez J., Rathz D., Petrashevskaya N., et al. β1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure. Nat Med 9 (2003) 1300-1305
6. Wagoner L., Craft L., Zengel P., et al. Polymorphisms of the beta1-adrenergic receptor predict exercise capacity in heart failure. Am Heart J 144 (2002) 840-846
7. Iglarz M., Benessiano J., Philip I., et al. Preproendothelin-1 gene polymorphism is related to a change in vascular reactivity in the human mammary artery in vitro. Hypertension 39 (2002) 209-213
8. Tiret L., Poirier O., Hallet V., et al. The Lys198Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people. Hypertension 33 (1999) 1169-1174
9. Colombo M., Ciofini E., Paradossi U., et al. ET-1 Lys198Asn and ET (A) receptor H323H polymorphisms in heart failure. A case-control study. Cardiology 105 (2006) 246-252
10. Kozak M., Izakovicova Holla L., Krivan L., et al. Endothelin-1 gene polymorphism in patients with malignant arrhythmias. J Cardiovasc Pharmacol 44 suppl (2004) S92-S95
11. Henrion D., and Laher I. Potentiation of norepinephrine-induced contractions by endothelin-1 in the rabbit aorta. Hypertension 22 (1993) 78-83